Loading…

Additive Impact of Cardiometabolic Multimorbidity and Depression on Cognitive Decline: Findings from Multi‐Regional Cohorts and Generalization from Community to Clinic

Background To estimate the additive associations of cardiometabolic multimorbidity (CMM) and depression on long‐term cognitive trajectory in multi‐regional cohorts and validate the generalizability of the findings in varying clinical settings. Method Data harmonization was performed across 14 longit...

Full description

Saved in:
Bibliographic Details
Published in:Alzheimer's & dementia 2024-12, Vol.20 (S7), p.n/a
Main Authors: Zhao, Xuhao, Yan, Yifan, Lipnicki, Darren M., Pang, Ting, Chen, Christopher, Wong, Tien Yin, Yu Cheng, Ching, Venketasubramanian, Narayanaswamy, Chong, Eddie, Costa, Erico, Lipton, Richard B., Katz, Mindy J., Ritchie, Karen, Carriere, Isabelle, Scarmeas, Nikolaos, Gureje, Oye, Hendrie, Hugh C, Gao, Sujuan, Guerra, Ricardo Oliveira, Rolandi, Elena, Riedel‐Heller, Steffi G., Ganguli, Mary, Aiello, Allison E, Ho, Roger Chun‐Man, Sanchez‐Juan, Pascual, Lobo, Antonio, Sachdev, Perminder S., Xu, Xiaolin, Xu, Xin
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page n/a
container_issue S7
container_start_page
container_title Alzheimer's & dementia
container_volume 20
creator Zhao, Xuhao
Yan, Yifan
Lipnicki, Darren M.
Pang, Ting
Chen, Christopher
Wong, Tien Yin
Yu Cheng, Ching
Venketasubramanian, Narayanaswamy
Chong, Eddie
Costa, Erico
Lipton, Richard B.
Katz, Mindy J.
Ritchie, Karen
Carriere, Isabelle
Scarmeas, Nikolaos
Gureje, Oye
Hendrie, Hugh C
Gao, Sujuan
Guerra, Ricardo Oliveira
Rolandi, Elena
Riedel‐Heller, Steffi G.
Ganguli, Mary
Aiello, Allison E
Ho, Roger Chun‐Man
Sanchez‐Juan, Pascual
Lobo, Antonio
Sachdev, Perminder S.
Xu, Xiaolin
Xu, Xin
description Background To estimate the additive associations of cardiometabolic multimorbidity (CMM) and depression on long‐term cognitive trajectory in multi‐regional cohorts and validate the generalizability of the findings in varying clinical settings. Method Data harmonization was performed across 14 longitudinal cohort studies within the Cohort Studies of Memory in an International Consortium (COSMIC) group, spanning North America, South America, Europe, Africa, Asia, and Australia. Three external validation studies with distinct settings were employed to assess generalizability. Cross‐sectional and longitudinal analyses were conducted. CMM was defined as: 1) CMM5: ≥ 2 among hypertension, hyperlipidemia, diabetes mellitus, stroke, and heart disease and 2) CMM3 (aligned with previous studies): ≥ 2 among diabetes mellitus, stroke, and heart disease. Depression was identified using the Geriatric Depression Scale, Center for Epidemiological Studies‐Depression scale, or medical history. A one‐step individual participant data meta‐analysis was utilized to investigate associations between the co‐occurrence of CMM and depression and cognitive outcomes in the COSMIC studies. Stratified analyses were conducted based on baseline dementia status, demographics, and APOE genotype. Repeated analyses were performed in external validation studies for generalization. Result Of the 32,450 older adults in the 14 COSMIC cohorts, we included 31,243 participants with complete data on CMM, depression, and cognitive assessment for cross‐sectional analyses. Among them, 23,242 who had at least 1 follow‐up cognitive assessment were included in the longitudinal analyses. From the three external studies we included 1964 participants, representing 3 multi‐ethnic Asian elderly cohorts (community cohort, memory clinic cohort, and stroke cohort). In the COSMIC studies analysis, the co‐occurrence of CMM and depression was associated with both cross‐sectional cognitive performance (β = ‐0.20, 95%CI = (‐0.25,‐0.16) for CMM5 and depression, β = ‐0.17, (95%CI = ‐0.044,‐0.031) for CMM3 and depression), and rate of cognitive decline (β = ‐0.038, 95%CI = (‐0.25,‐0.16) for CMM5 and depression, β = ‐0.023, (95%CI = ‐0.036, ‐0.009) for CMM3 and depression). This combined effect remained consistent across different subgroups particularly among participants without dementia. These findings were reproduced in the three external validation studies. Conclusion Our study demonstrated an additive effect between CM
doi_str_mv 10.1002/alz.087254
format article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11714637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ALZ087254</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1694-31eb2648bd7d83bfc1cded39aa6fd41f27766c9790e4216b9c88bb5970944c203</originalsourceid><addsrcrecordid>eNp9kctKxDAUhosoeN34BFkLo0mbNq0bGeoVRgTRjZuQy-kYaZMh6SjjykfwNXwtn8TMdBDcCIETOP_3JfAnySHBxwTj9ES078e4ZGlON5IdkufpKE9Ztfl7L_B2shvCC8YUlyTfSb7GWpvevAK66WZC9cg1qBZeG9dBL6RrjUK387Y3nfPSxOgCCavROcw8hGCcRfHUbmoHyTmo1lg4RZfGamOnATXedYPh--PzHqYREW0knp3vw8p1BRa8aM276Je-FVC7rpvb5Wu9Q3VUGrWfbDWiDXCwnnvJ4-XFQ309mtxd3dTjyUiRoqKjjIBMC1pKzXSZyUYRpUFnlRBFoylpUsaKQlWswkBTUshKlaWUecVwRalKcbaXnA3e2Vx2oBXYPv6Oz7zphF9wJwz_u7HmmU_dKyeEEVpkLBqOBoPyLgQPzS9MMF_WxGNNfKgphskQfjMtLP5J8vHkac38AHHJm38</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Additive Impact of Cardiometabolic Multimorbidity and Depression on Cognitive Decline: Findings from Multi‐Regional Cohorts and Generalization from Community to Clinic</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley-Blackwell Titles (Open access)</source><source>PubMed Central</source><creator>Zhao, Xuhao ; Yan, Yifan ; Lipnicki, Darren M. ; Pang, Ting ; Chen, Christopher ; Wong, Tien Yin ; Yu Cheng, Ching ; Venketasubramanian, Narayanaswamy ; Chong, Eddie ; Costa, Erico ; Lipton, Richard B. ; Katz, Mindy J. ; Ritchie, Karen ; Carriere, Isabelle ; Scarmeas, Nikolaos ; Gureje, Oye ; Hendrie, Hugh C ; Gao, Sujuan ; Guerra, Ricardo Oliveira ; Rolandi, Elena ; Riedel‐Heller, Steffi G. ; Ganguli, Mary ; Aiello, Allison E ; Ho, Roger Chun‐Man ; Sanchez‐Juan, Pascual ; Lobo, Antonio ; Sachdev, Perminder S. ; Xu, Xiaolin ; Xu, Xin</creator><creatorcontrib>Zhao, Xuhao ; Yan, Yifan ; Lipnicki, Darren M. ; Pang, Ting ; Chen, Christopher ; Wong, Tien Yin ; Yu Cheng, Ching ; Venketasubramanian, Narayanaswamy ; Chong, Eddie ; Costa, Erico ; Lipton, Richard B. ; Katz, Mindy J. ; Ritchie, Karen ; Carriere, Isabelle ; Scarmeas, Nikolaos ; Gureje, Oye ; Hendrie, Hugh C ; Gao, Sujuan ; Guerra, Ricardo Oliveira ; Rolandi, Elena ; Riedel‐Heller, Steffi G. ; Ganguli, Mary ; Aiello, Allison E ; Ho, Roger Chun‐Man ; Sanchez‐Juan, Pascual ; Lobo, Antonio ; Sachdev, Perminder S. ; Xu, Xiaolin ; Xu, Xin ; Cohort Studies of Memory in an International Consortium (COSMIC)</creatorcontrib><description>Background To estimate the additive associations of cardiometabolic multimorbidity (CMM) and depression on long‐term cognitive trajectory in multi‐regional cohorts and validate the generalizability of the findings in varying clinical settings. Method Data harmonization was performed across 14 longitudinal cohort studies within the Cohort Studies of Memory in an International Consortium (COSMIC) group, spanning North America, South America, Europe, Africa, Asia, and Australia. Three external validation studies with distinct settings were employed to assess generalizability. Cross‐sectional and longitudinal analyses were conducted. CMM was defined as: 1) CMM5: ≥ 2 among hypertension, hyperlipidemia, diabetes mellitus, stroke, and heart disease and 2) CMM3 (aligned with previous studies): ≥ 2 among diabetes mellitus, stroke, and heart disease. Depression was identified using the Geriatric Depression Scale, Center for Epidemiological Studies‐Depression scale, or medical history. A one‐step individual participant data meta‐analysis was utilized to investigate associations between the co‐occurrence of CMM and depression and cognitive outcomes in the COSMIC studies. Stratified analyses were conducted based on baseline dementia status, demographics, and APOE genotype. Repeated analyses were performed in external validation studies for generalization. Result Of the 32,450 older adults in the 14 COSMIC cohorts, we included 31,243 participants with complete data on CMM, depression, and cognitive assessment for cross‐sectional analyses. Among them, 23,242 who had at least 1 follow‐up cognitive assessment were included in the longitudinal analyses. From the three external studies we included 1964 participants, representing 3 multi‐ethnic Asian elderly cohorts (community cohort, memory clinic cohort, and stroke cohort). In the COSMIC studies analysis, the co‐occurrence of CMM and depression was associated with both cross‐sectional cognitive performance (β = ‐0.20, 95%CI = (‐0.25,‐0.16) for CMM5 and depression, β = ‐0.17, (95%CI = ‐0.044,‐0.031) for CMM3 and depression), and rate of cognitive decline (β = ‐0.038, 95%CI = (‐0.25,‐0.16) for CMM5 and depression, β = ‐0.023, (95%CI = ‐0.036, ‐0.009) for CMM3 and depression). This combined effect remained consistent across different subgroups particularly among participants without dementia. These findings were reproduced in the three external validation studies. Conclusion Our study demonstrated an additive effect between CMM and depression on cognitive decline. Targeting both cardiometabolic and psychological conditions could lead to greater effectiveness in delaying or preventing cognitive decline.</description><identifier>ISSN: 1552-5260</identifier><identifier>EISSN: 1552-5279</identifier><identifier>DOI: 10.1002/alz.087254</identifier><language>eng</language><publisher>Hoboken: John Wiley and Sons Inc</publisher><subject>Public Health</subject><ispartof>Alzheimer's &amp; dementia, 2024-12, Vol.20 (S7), p.n/a</ispartof><rights>2024 The Alzheimer's Association. published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11714637/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11714637/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11541,27901,27902,46027,46451,53766,53768</link.rule.ids></links><search><creatorcontrib>Zhao, Xuhao</creatorcontrib><creatorcontrib>Yan, Yifan</creatorcontrib><creatorcontrib>Lipnicki, Darren M.</creatorcontrib><creatorcontrib>Pang, Ting</creatorcontrib><creatorcontrib>Chen, Christopher</creatorcontrib><creatorcontrib>Wong, Tien Yin</creatorcontrib><creatorcontrib>Yu Cheng, Ching</creatorcontrib><creatorcontrib>Venketasubramanian, Narayanaswamy</creatorcontrib><creatorcontrib>Chong, Eddie</creatorcontrib><creatorcontrib>Costa, Erico</creatorcontrib><creatorcontrib>Lipton, Richard B.</creatorcontrib><creatorcontrib>Katz, Mindy J.</creatorcontrib><creatorcontrib>Ritchie, Karen</creatorcontrib><creatorcontrib>Carriere, Isabelle</creatorcontrib><creatorcontrib>Scarmeas, Nikolaos</creatorcontrib><creatorcontrib>Gureje, Oye</creatorcontrib><creatorcontrib>Hendrie, Hugh C</creatorcontrib><creatorcontrib>Gao, Sujuan</creatorcontrib><creatorcontrib>Guerra, Ricardo Oliveira</creatorcontrib><creatorcontrib>Rolandi, Elena</creatorcontrib><creatorcontrib>Riedel‐Heller, Steffi G.</creatorcontrib><creatorcontrib>Ganguli, Mary</creatorcontrib><creatorcontrib>Aiello, Allison E</creatorcontrib><creatorcontrib>Ho, Roger Chun‐Man</creatorcontrib><creatorcontrib>Sanchez‐Juan, Pascual</creatorcontrib><creatorcontrib>Lobo, Antonio</creatorcontrib><creatorcontrib>Sachdev, Perminder S.</creatorcontrib><creatorcontrib>Xu, Xiaolin</creatorcontrib><creatorcontrib>Xu, Xin</creatorcontrib><creatorcontrib>Cohort Studies of Memory in an International Consortium (COSMIC)</creatorcontrib><title>Additive Impact of Cardiometabolic Multimorbidity and Depression on Cognitive Decline: Findings from Multi‐Regional Cohorts and Generalization from Community to Clinic</title><title>Alzheimer's &amp; dementia</title><description>Background To estimate the additive associations of cardiometabolic multimorbidity (CMM) and depression on long‐term cognitive trajectory in multi‐regional cohorts and validate the generalizability of the findings in varying clinical settings. Method Data harmonization was performed across 14 longitudinal cohort studies within the Cohort Studies of Memory in an International Consortium (COSMIC) group, spanning North America, South America, Europe, Africa, Asia, and Australia. Three external validation studies with distinct settings were employed to assess generalizability. Cross‐sectional and longitudinal analyses were conducted. CMM was defined as: 1) CMM5: ≥ 2 among hypertension, hyperlipidemia, diabetes mellitus, stroke, and heart disease and 2) CMM3 (aligned with previous studies): ≥ 2 among diabetes mellitus, stroke, and heart disease. Depression was identified using the Geriatric Depression Scale, Center for Epidemiological Studies‐Depression scale, or medical history. A one‐step individual participant data meta‐analysis was utilized to investigate associations between the co‐occurrence of CMM and depression and cognitive outcomes in the COSMIC studies. Stratified analyses were conducted based on baseline dementia status, demographics, and APOE genotype. Repeated analyses were performed in external validation studies for generalization. Result Of the 32,450 older adults in the 14 COSMIC cohorts, we included 31,243 participants with complete data on CMM, depression, and cognitive assessment for cross‐sectional analyses. Among them, 23,242 who had at least 1 follow‐up cognitive assessment were included in the longitudinal analyses. From the three external studies we included 1964 participants, representing 3 multi‐ethnic Asian elderly cohorts (community cohort, memory clinic cohort, and stroke cohort). In the COSMIC studies analysis, the co‐occurrence of CMM and depression was associated with both cross‐sectional cognitive performance (β = ‐0.20, 95%CI = (‐0.25,‐0.16) for CMM5 and depression, β = ‐0.17, (95%CI = ‐0.044,‐0.031) for CMM3 and depression), and rate of cognitive decline (β = ‐0.038, 95%CI = (‐0.25,‐0.16) for CMM5 and depression, β = ‐0.023, (95%CI = ‐0.036, ‐0.009) for CMM3 and depression). This combined effect remained consistent across different subgroups particularly among participants without dementia. These findings were reproduced in the three external validation studies. Conclusion Our study demonstrated an additive effect between CMM and depression on cognitive decline. Targeting both cardiometabolic and psychological conditions could lead to greater effectiveness in delaying or preventing cognitive decline.</description><subject>Public Health</subject><issn>1552-5260</issn><issn>1552-5279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp9kctKxDAUhosoeN34BFkLo0mbNq0bGeoVRgTRjZuQy-kYaZMh6SjjykfwNXwtn8TMdBDcCIETOP_3JfAnySHBxwTj9ES078e4ZGlON5IdkufpKE9Ztfl7L_B2shvCC8YUlyTfSb7GWpvevAK66WZC9cg1qBZeG9dBL6RrjUK387Y3nfPSxOgCCavROcw8hGCcRfHUbmoHyTmo1lg4RZfGamOnATXedYPh--PzHqYREW0knp3vw8p1BRa8aM276Je-FVC7rpvb5Wu9Q3VUGrWfbDWiDXCwnnvJ4-XFQ309mtxd3dTjyUiRoqKjjIBMC1pKzXSZyUYRpUFnlRBFoylpUsaKQlWswkBTUshKlaWUecVwRalKcbaXnA3e2Vx2oBXYPv6Oz7zphF9wJwz_u7HmmU_dKyeEEVpkLBqOBoPyLgQPzS9MMF_WxGNNfKgphskQfjMtLP5J8vHkac38AHHJm38</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Zhao, Xuhao</creator><creator>Yan, Yifan</creator><creator>Lipnicki, Darren M.</creator><creator>Pang, Ting</creator><creator>Chen, Christopher</creator><creator>Wong, Tien Yin</creator><creator>Yu Cheng, Ching</creator><creator>Venketasubramanian, Narayanaswamy</creator><creator>Chong, Eddie</creator><creator>Costa, Erico</creator><creator>Lipton, Richard B.</creator><creator>Katz, Mindy J.</creator><creator>Ritchie, Karen</creator><creator>Carriere, Isabelle</creator><creator>Scarmeas, Nikolaos</creator><creator>Gureje, Oye</creator><creator>Hendrie, Hugh C</creator><creator>Gao, Sujuan</creator><creator>Guerra, Ricardo Oliveira</creator><creator>Rolandi, Elena</creator><creator>Riedel‐Heller, Steffi G.</creator><creator>Ganguli, Mary</creator><creator>Aiello, Allison E</creator><creator>Ho, Roger Chun‐Man</creator><creator>Sanchez‐Juan, Pascual</creator><creator>Lobo, Antonio</creator><creator>Sachdev, Perminder S.</creator><creator>Xu, Xiaolin</creator><creator>Xu, Xin</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202412</creationdate><title>Additive Impact of Cardiometabolic Multimorbidity and Depression on Cognitive Decline: Findings from Multi‐Regional Cohorts and Generalization from Community to Clinic</title><author>Zhao, Xuhao ; Yan, Yifan ; Lipnicki, Darren M. ; Pang, Ting ; Chen, Christopher ; Wong, Tien Yin ; Yu Cheng, Ching ; Venketasubramanian, Narayanaswamy ; Chong, Eddie ; Costa, Erico ; Lipton, Richard B. ; Katz, Mindy J. ; Ritchie, Karen ; Carriere, Isabelle ; Scarmeas, Nikolaos ; Gureje, Oye ; Hendrie, Hugh C ; Gao, Sujuan ; Guerra, Ricardo Oliveira ; Rolandi, Elena ; Riedel‐Heller, Steffi G. ; Ganguli, Mary ; Aiello, Allison E ; Ho, Roger Chun‐Man ; Sanchez‐Juan, Pascual ; Lobo, Antonio ; Sachdev, Perminder S. ; Xu, Xiaolin ; Xu, Xin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1694-31eb2648bd7d83bfc1cded39aa6fd41f27766c9790e4216b9c88bb5970944c203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Public Health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Xuhao</creatorcontrib><creatorcontrib>Yan, Yifan</creatorcontrib><creatorcontrib>Lipnicki, Darren M.</creatorcontrib><creatorcontrib>Pang, Ting</creatorcontrib><creatorcontrib>Chen, Christopher</creatorcontrib><creatorcontrib>Wong, Tien Yin</creatorcontrib><creatorcontrib>Yu Cheng, Ching</creatorcontrib><creatorcontrib>Venketasubramanian, Narayanaswamy</creatorcontrib><creatorcontrib>Chong, Eddie</creatorcontrib><creatorcontrib>Costa, Erico</creatorcontrib><creatorcontrib>Lipton, Richard B.</creatorcontrib><creatorcontrib>Katz, Mindy J.</creatorcontrib><creatorcontrib>Ritchie, Karen</creatorcontrib><creatorcontrib>Carriere, Isabelle</creatorcontrib><creatorcontrib>Scarmeas, Nikolaos</creatorcontrib><creatorcontrib>Gureje, Oye</creatorcontrib><creatorcontrib>Hendrie, Hugh C</creatorcontrib><creatorcontrib>Gao, Sujuan</creatorcontrib><creatorcontrib>Guerra, Ricardo Oliveira</creatorcontrib><creatorcontrib>Rolandi, Elena</creatorcontrib><creatorcontrib>Riedel‐Heller, Steffi G.</creatorcontrib><creatorcontrib>Ganguli, Mary</creatorcontrib><creatorcontrib>Aiello, Allison E</creatorcontrib><creatorcontrib>Ho, Roger Chun‐Man</creatorcontrib><creatorcontrib>Sanchez‐Juan, Pascual</creatorcontrib><creatorcontrib>Lobo, Antonio</creatorcontrib><creatorcontrib>Sachdev, Perminder S.</creatorcontrib><creatorcontrib>Xu, Xiaolin</creatorcontrib><creatorcontrib>Xu, Xin</creatorcontrib><creatorcontrib>Cohort Studies of Memory in an International Consortium (COSMIC)</creatorcontrib><collection>Wiley-Blackwell Titles (Open access)</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Alzheimer's &amp; dementia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Xuhao</au><au>Yan, Yifan</au><au>Lipnicki, Darren M.</au><au>Pang, Ting</au><au>Chen, Christopher</au><au>Wong, Tien Yin</au><au>Yu Cheng, Ching</au><au>Venketasubramanian, Narayanaswamy</au><au>Chong, Eddie</au><au>Costa, Erico</au><au>Lipton, Richard B.</au><au>Katz, Mindy J.</au><au>Ritchie, Karen</au><au>Carriere, Isabelle</au><au>Scarmeas, Nikolaos</au><au>Gureje, Oye</au><au>Hendrie, Hugh C</au><au>Gao, Sujuan</au><au>Guerra, Ricardo Oliveira</au><au>Rolandi, Elena</au><au>Riedel‐Heller, Steffi G.</au><au>Ganguli, Mary</au><au>Aiello, Allison E</au><au>Ho, Roger Chun‐Man</au><au>Sanchez‐Juan, Pascual</au><au>Lobo, Antonio</au><au>Sachdev, Perminder S.</au><au>Xu, Xiaolin</au><au>Xu, Xin</au><aucorp>Cohort Studies of Memory in an International Consortium (COSMIC)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Additive Impact of Cardiometabolic Multimorbidity and Depression on Cognitive Decline: Findings from Multi‐Regional Cohorts and Generalization from Community to Clinic</atitle><jtitle>Alzheimer's &amp; dementia</jtitle><date>2024-12</date><risdate>2024</risdate><volume>20</volume><issue>S7</issue><epage>n/a</epage><issn>1552-5260</issn><eissn>1552-5279</eissn><abstract>Background To estimate the additive associations of cardiometabolic multimorbidity (CMM) and depression on long‐term cognitive trajectory in multi‐regional cohorts and validate the generalizability of the findings in varying clinical settings. Method Data harmonization was performed across 14 longitudinal cohort studies within the Cohort Studies of Memory in an International Consortium (COSMIC) group, spanning North America, South America, Europe, Africa, Asia, and Australia. Three external validation studies with distinct settings were employed to assess generalizability. Cross‐sectional and longitudinal analyses were conducted. CMM was defined as: 1) CMM5: ≥ 2 among hypertension, hyperlipidemia, diabetes mellitus, stroke, and heart disease and 2) CMM3 (aligned with previous studies): ≥ 2 among diabetes mellitus, stroke, and heart disease. Depression was identified using the Geriatric Depression Scale, Center for Epidemiological Studies‐Depression scale, or medical history. A one‐step individual participant data meta‐analysis was utilized to investigate associations between the co‐occurrence of CMM and depression and cognitive outcomes in the COSMIC studies. Stratified analyses were conducted based on baseline dementia status, demographics, and APOE genotype. Repeated analyses were performed in external validation studies for generalization. Result Of the 32,450 older adults in the 14 COSMIC cohorts, we included 31,243 participants with complete data on CMM, depression, and cognitive assessment for cross‐sectional analyses. Among them, 23,242 who had at least 1 follow‐up cognitive assessment were included in the longitudinal analyses. From the three external studies we included 1964 participants, representing 3 multi‐ethnic Asian elderly cohorts (community cohort, memory clinic cohort, and stroke cohort). In the COSMIC studies analysis, the co‐occurrence of CMM and depression was associated with both cross‐sectional cognitive performance (β = ‐0.20, 95%CI = (‐0.25,‐0.16) for CMM5 and depression, β = ‐0.17, (95%CI = ‐0.044,‐0.031) for CMM3 and depression), and rate of cognitive decline (β = ‐0.038, 95%CI = (‐0.25,‐0.16) for CMM5 and depression, β = ‐0.023, (95%CI = ‐0.036, ‐0.009) for CMM3 and depression). This combined effect remained consistent across different subgroups particularly among participants without dementia. These findings were reproduced in the three external validation studies. Conclusion Our study demonstrated an additive effect between CMM and depression on cognitive decline. Targeting both cardiometabolic and psychological conditions could lead to greater effectiveness in delaying or preventing cognitive decline.</abstract><cop>Hoboken</cop><pub>John Wiley and Sons Inc</pub><doi>10.1002/alz.087254</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-5260
ispartof Alzheimer's & dementia, 2024-12, Vol.20 (S7), p.n/a
issn 1552-5260
1552-5279
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11714637
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley-Blackwell Titles (Open access); PubMed Central
subjects Public Health
title Additive Impact of Cardiometabolic Multimorbidity and Depression on Cognitive Decline: Findings from Multi‐Regional Cohorts and Generalization from Community to Clinic
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T11%3A34%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Additive%20Impact%20of%20Cardiometabolic%20Multimorbidity%20and%20Depression%20on%20Cognitive%20Decline:%20Findings%20from%20Multi%E2%80%90Regional%20Cohorts%20and%20Generalization%20from%20Community%20to%20Clinic&rft.jtitle=Alzheimer's%20&%20dementia&rft.au=Zhao,%20Xuhao&rft.aucorp=Cohort%20Studies%20of%20Memory%20in%20an%20International%20Consortium%20(COSMIC)&rft.date=2024-12&rft.volume=20&rft.issue=S7&rft.epage=n/a&rft.issn=1552-5260&rft.eissn=1552-5279&rft_id=info:doi/10.1002/alz.087254&rft_dat=%3Cwiley_pubme%3EALZ087254%3C/wiley_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1694-31eb2648bd7d83bfc1cded39aa6fd41f27766c9790e4216b9c88bb5970944c203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true